Association of Afamin Concentration with Type 1 and Type 2 Diabetes Mellitus

  • Rebwar Jalal Ali Department of Basic Science-Biochemistry Unit, College of Medicine, Hawler Medical University-Erbil, Erbil City, Kurdistan Region, Iraq
  • Sardar Nouri Ahmed Department of Basic Science-Biochemistry Unit, College of Medicine, Hawler Medical University-Erbil, Erbil City, Kurdistan Region, Iraq
Keywords: Serum afamin, diabetes mellitus, type 1 diabetes, type 2 diabetes

Abstract

      Afamin is a protein in humans that plays a major role in the regulation of glucose metabolism, insulin sensitivity, so it may be related to diabetes mellitus. The aim of this study to evaluate the afamin concentration level in diabetic patients. This study was a case-control study blood samples were collected from 130 patients of  Diabetes mellitus (DM) which divided into two groups (65 types1 DM and 65 type 2 DM) from Laila Qasim center for diabetes in Erbil City. In addition90 healthy volunteers used as a control. Serum was separated to determine afamin concentration. The results showed that the level of afamin in type 2 diabetic patients  were significantly higher than those of healthy adults  (75.09 + 10.09 mg/L), and (65.62 + 7.18 mg/L) respectively, No significant differences in the concentration of afamin were observed between control and type 1 DM were (58.47 ± 8.13), and (63.07 ± 5.53) respectively. Our finding showed that increase serum afamin concentration in type 2 diabetes patients can be used as a biomarker for predicting diabetes mellitus.

Downloads

Download data is not yet available.

References

COMPANY, F. T. 2020. Human AFM(Afamin) ELISA Kit [Online]. Available: https://www.fn-test.com/product/eh2493/ [Accessed].
DELHI, N. J. R. T. O. D. M. N. E. N. D. N. D. J. B. M. P. 2012. Jaypee Brothers Medical Publishers.
DI LEO, G. & SARDANELLI, F. J. E. R. E. 2020. Statistical significance: p value, 0.05 threshold, and applications to radiomics—reasons for a conservative approach. 4, 1-8.
IBRAHIM, M. A. 2018. Metformin ameliorates diabetes mellitus in Kurds patients by attenuation of serum cortisol and copper levels. ZANCO Journal of Pure and Applied Sciences, 30, 48-56.
JERKOVIC, L., VOEGELE, A. F., CHWATAL, S., KRONENBERG, F., RADCLIFFE, C. M., WORMALD, M. R., LOBENTANZ, E. M., EZEH, B., ELLER, P., DEJORI, N., DIEPLINGER, B., LOTTSPEICH, F., SATTLER, W., UHR, M., MECHTLER, K., DWEK, R. A., RUDD, P. M., BAIER, G. & DIEPLINGER, H. 2005. Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J Proteome Res, 4, 889-99.
KOLLERITS, B., LAMINA, C., HUTH, C., MARQUES-VIDAL, P., KIECHL, S., SEPPALA, I., COOPER, J., HUNT, S. C., MEISINGER, C., HERDER, C., KEDENKO, L., WILLEIT, J., THORAND, B., DAHNHARDT, D., STOCKL, D., WILLEIT, K., RODEN, M., RATHMANN, W., PAULWEBER, B., PETERS, A., KAHONEN, M., LEHTIMAKI, T., RAITAKARI, O. T., HUMPHRIES, S. E., VOLLENWEIDER, P., DIEPLINGER, H. & KRONENBERG, F. 2017. Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals. Diabetes Care, 40, 1386-1393.
KONINGER, A., MATHAN, A., MACH, P., FRANK, M., SCHMIDT, B., SCHLEUSSNER, E., KIMMIG, R., GELLHAUS, A. & DIEPLINGER, H. 2018. Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study. Reprod Biol Endocrinol, 16, 30.
KRONENBERG, F. & DIEPLINGER, H. J. C. L. 2015. Afamin is a promising novel marker for metabolic syndrome and related diseases. Clinical Lipidology, 10, 207-3.
KRONENBERG, F., KOLLERITS, B., KIECHL, S., LAMINA, C., KEDENKO, L., MEISINGER, C., WILLEIT, J., HUTH, C., WIETZORREK, G., ALTMANN, M. E., THORAND, B., MELMER, A., DAHNHARDT, D., SANTER, P., RATHMANN, W., PAULWEBER, B., KOENIG, W., PETERS, A., ADHAM, I. M. & DIEPLINGER, H. 2014. Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circ Cardiovasc Genet, 7, 822-9.
LESLIE, R. D., PALMER, J., SCHLOOT, N. C. & LERNMARK, A. J. D. 2016. Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment. 59, 13-20.
LICHENSTEIN, H. S., LYONS, D. E., WURFEL, M. M., JOHNSON, D. A., MCGINLEY, M. D., LEIDLI, J. C., TROLLINGER, D. B., MAYER, J. P., WRIGHT, S. D. & ZUKOWSKI, M. M. 1994. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem, 269, 18149-54.
NOORUL, A. 2018. An Overview of Diabetes Mellitus; Types, Complications, and Management. International Journal of Nursing Science Practice and Research, 4, 119-124.
POLKOWSKA, A., PASIEROWSKA, I. E., PASLAWSKA, M., PAWLUCZUK, E. & BOSSOWSKI, A. 2019. Assessment of Serum Concentrations of Adropin, Afamin, and Neudesin in Children with Type 1 Diabetes. Biomed Res Int, 2019, 6128410.
SEEBER, B., MORANDELL, E., LUNGER, F., WILDT, L. & DIEPLINGER, H. 2014. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reprod Biol Endocrinol, 12, 88.
VOS, T., FLAXMAN, A. D., NAGHAVI, M., LOZANO, R., MICHAUD, C., EZZATI, M., SHIBUYA, K., SALOMON, J. A., ABDALLA, S. & ABOYANS, V. J. T. L. 2012. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. 380, 2163-2196.
WANG, W. K., TSAI, C. H., LIU, Y. W., LAI, C. C., HUANG, C. C. & SHEEN-CHEN, S. M. 2020. Afamin expression in breast cancer. Asian J Surg, 43, 750-754.
ZHENG, Y., LEY, S. H. & HU, F. B. 2018. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol, 14, 88-98.
Published
2021-10-20
How to Cite
Ali, R. and Nouri Ahmed, S. (2021) “Association of Afamin Concentration with Type 1 and Type 2 Diabetes Mellitus”, Zanco Journal of Pure and Applied Sciences, 33(5), pp. 69-75. doi: 10.21271/ZJPAS.33.5.8.
Section
Biology and Medical Researches